Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Pardes Biosciences (NASDAQ:PRDS) reported its Q1 earnings results on Friday, May 5, 2023 at 04:01 PM.
Here's what investors need to know about the announcement.
Pardes Biosciences beat estimated earnings by 26.83%, reporting an EPS of $-0.3 versus an estimate of $-0.41.
Revenue was down $0 from the same period last year.
Last quarter the company beat on EPS by $0.09 which was followed by a 3.85% increase in the share price the next day.
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for Pardes Biosciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: PRDS